CHEBI:63637 - vemurafenib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name vemurafenib
ChEBI ID CHEBI:63637
Definition A pyrrolopyridine that is 1H-pyrrolo[2,3-b]pyridine which is substituted at position 5 by a p-chlorophenyl group and at positions 3 by a 3-amino-2,6-difluorobenzoyl group, the amino group of which has undergone formal condensation with propane-1-sulfonic acid to give the corresponding sulfonamide. An inhibitor of BRAF and other kinases.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Anonymous
Kalpana P
Secondary ChEBI IDs CHEBI:194457
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C23H18ClF2N3O3S
Net Charge 0
Average Mass 489.920
Monoisotopic Mass 489.07255
InChI InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)
InChIKey GPXBXXGIAQBQNI-UHFFFAOYSA-N
SMILES CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(C=N3)C2=CC=C(Cl)C=C2)=C1F
Roles Classification
Biological Role(s): B-Raf inhibitor
A serine/threonine kinase inhibitor that specifically inhibits human mutant serine/threonine kinase (B-Raf)
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing vemurafenib (CHEBI:63637) has role antineoplastic agent (CHEBI:35610)
vemurafenib (CHEBI:63637) has role B-Raf inhibitor (CHEBI:75047)
vemurafenib (CHEBI:63637) is a aromatic ketone (CHEBI:76224)
vemurafenib (CHEBI:63637) is a difluorobenzene (CHEBI:38582)
vemurafenib (CHEBI:63637) is a monochlorobenzenes (CHEBI:83403)
vemurafenib (CHEBI:63637) is a pyrrolopyridine (CHEBI:46771)
vemurafenib (CHEBI:63637) is a sulfonamide (CHEBI:35358)
IUPAC Name
N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide
INNs Sources
vemurafenib WHO MedNet
vemurafenib WHO MedNet
vémurafénib WHO MedNet
vemurafenibum WHO MedNet
Synonyms Sources
PLX 4032 ChEBI
PLX-4032 DrugBank
PLX4032 DrugBank
RG 7204 ChEBI
RG-7204 DrugBank
RG7204 DrugBank
Ro 51-85426 DrugCentral
RO 5185426 DrugCentral
RO-51-85426 DrugBank
RO-5185426 DrugBank
RO5185426 DrugBank
Brand Name Source
Zelboraf KEGG DRUG
Manual Xrefs Databases
032 PDBeChem
4185 DrugCentral
D09996 KEGG DRUG
DB08881 DrugBank
LSM-1068 LINCS
Vemurafenib Wikipedia
WO2010114928 Patent
View more database links
Registry Numbers Types Sources
12833468 Reaxys Registry Number Reaxys
918504-65-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
21609436 PubMed citation Europe PMC
21639808 PubMed citation Europe PMC
22028422 PubMed citation Europe PMC
22037033 PubMed citation Europe PMC
22083257 PubMed citation Europe PMC
22180495 PubMed citation Europe PMC
23866896 PubMed citation Europe PMC
29999925 PubMed citation Europe PMC
33595357 PubMed citation Europe PMC
34433660 PubMed citation Europe PMC
35740068 PubMed citation Europe PMC
36396045 PubMed citation Europe PMC
36431901 PubMed citation Europe PMC
36598578 PubMed citation Europe PMC
36612138 PubMed citation Europe PMC
36713531 PubMed citation Europe PMC
36765875 PubMed citation Europe PMC
36855200 PubMed citation Europe PMC
36906728 PubMed citation Europe PMC
36977328 PubMed citation Europe PMC
37021539 PubMed citation Europe PMC
37106808 PubMed citation Europe PMC
37215493 PubMed citation Europe PMC
37216396 PubMed citation Europe PMC
37309702 PubMed citation Europe PMC
37325052 PubMed citation Europe PMC
37419396 PubMed citation Europe PMC
37436162 PubMed citation Europe PMC
37446932 PubMed citation Europe PMC
37456058 PubMed citation Europe PMC
37459870 PubMed citation Europe PMC
37459873 PubMed citation Europe PMC
Last Modified
20 July 2023